Cetocycline, Tetracycline Analog: In Vitro Studies of Antimicrobial Activity, Serum Binding, Lipid Solubility, and Uptake by Bacteria

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1978-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.13.4.598PMID 666291PMCID PMC352294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uptake of antibiotics by human erythrocytes.

  1976cited by this paper
• Chelocardin-Inducible Resistance in Escherichia coli Bearing R Plasmids

  1976cited by this paper
• Distressing side-effects of minocycline hydrochloride.

  1976cited by this paper
• Cephalosporin and Aminoglycoside Concentrations in Peritoneal Capsular Fluid in Rabbits

  1976cited by this paper
• Relation Between Lipophilicity and Pharmacological Behavior of Minocycline, Doxycycline, Tetracycline, and Oxytetracycline in Dogs

  1975cited by this paper
• Comparison of Tetracycline and Minocycline Transport in Escherichia Coli

  1975cited by this paper
• Comparison of tetracycline and minocyclie transport in Escherichia Coli.

  1975cited by this paper
• Minocycline: Possible vestibular side-effects.

  1974cited by this paper
• Action of 12 Tetracyclines on Susceptible and Resistant Strains of Staphylococcus aureus

  1973cited by this paper
• Influence of Magnesium and Manganese on Some Biological and Physical Properties of Tetracycline

  1972cited by this paper
• The disposition of doxycyline by man and dog.

  1971cited by this paper
• Mode of action of beta-chelocardin.

  1971cited by this paper
• The Disposition of Doxycycline by Man and Dog

  1971cited by this paper
• Uptake of 3H-Tetracycline by Resistant and Sensitive Escherichia coli

  1971cited by this paper
• Structure–Activity Relationships in the Tetracycline Series

  1970cited by this paper
• Structure of chelocardin, a novel tetracycline antibiotic.

  1970cited by this paper
• Structure of chelocardin, a novel tetracycline antibiotic.

  1970cited by this paper
• pH-Partition behavior of tetracyclines.

  1969cited by this paper
• INHIBITORS OF PENICILLIN BINDING TO SERUM PROTEINS.

  1965cited by this paper
• INHIBITORS OF PENICILLIN BINDING TO SERUM PROTEINS.

  1964cited by this paper
• Clinical pharmacology of the tetracycline antibiotics

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Amycolatopsis ponsaeliensis sp. nov., a novel endophytic actinobacterium isolated from the root nodules of Alnus glutinosa

  2025cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models

  2023cites this paper
• Revision of the Absolute Configurations of Chelocardin and Amidochelocardin.

  2023cites this paper
• Looking Back to Amycolatopsis: History of the Antibiotic Discovery and Future Prospects

  2021cites this paper
• Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis

  2020cites this paper
• Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin

  2020cites this paper
• COMPARATIVE STUDIES BETWEEN RESIDUES OF NORFLOXACIN AND CIPROFLOXACIN IN BROILER CHICKENS WITH SPECIAL REFERENCE TO THEIR WITHDRAWAL TIME

  2020cites this paper
• Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics.

  2019cites this paper
• Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.

  2016cites this paper
• Rapid identification of atypical tetracyclines using tandem mass spectrometric fragmentation patterns.

  2015cites this paper
• Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering.

  2015cites this paper
• Identification of the chelocardin biosynthetic gene cluster from Amycolatopsis sulphurea: a platform for producing novel tetracycline antibiotics.

  2013cites this paper
• Phylum XXVI. Actinobacteria phyl. nov.

  2012cites this paper
• Coevolution: mankind and microbes.

  2008cites this paper
• Tetracycline Analogs Whose Primary Target Is Not the Bacterial Ribosome

  2003cites this paper
• Comparative pharmacokinetic profiles of two norfloxacin formulations after oral administration in rabbits.

  1998cites this paper
• Tetracycline analogs whose primary target is not the bacterial ribosome

  1994cites this paper
• Tetracyclines — extending the atypical spectrum

  1993cites this paper
• Tetracyclines-extending the atypical spectrum.

  1993cites this paper
• Tetracyclines, molecular and clinical aspects.

  1992cites this paper
• Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli

  1992cites this paper
• Microbiological conversion of 4-epi-cetocycline to 2-decarboxamido-2-acetyl-4-dedimethyl-9-methyltetracycline.

  1982cites this paper
• Heterogeneity of tetracycline resistance determinants in Streptococcus

  1982cites this paper